B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

KAPPA-TYPE

MOLECULAR TARGET

Kappa-type opioid receptor (human)

UniProt: P4114560 compounds

KAPPA-TYPE (Kappa-type opioid receptor (human)) is targeted by 60 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting KAPPA-TYPE

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Morphine1.956
2Clotrimazole1.393
3Econazole1.393
4Astemizole Antihistamine drug now withdrawn from1.102
5Disulfiram1.102
6Domperidone1.102
7Levorphanol1.102
8Miconazole1.102
9Nalbuphine1.102
10Naloxone1.102
11Ritonavir1.102
12Mianserin0.691
13Quetiapine Fumarate0.691
14Sertraline0.691
15Amitriptyline Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent0.691
16Amoxapine0.691
17Aprindine0.691
18Benzethonium Bactericidal cationic quaternary ammonium surfactant used as0.691
19Butorphanol0.691
20Chlorhexidine0.691
21Cilostazol0.691
22Clonidine0.691
23Codeine0.691
24Cyproterone0.691
25Danazol0.691
26Dextromethorphan Methyl analog of DEXTRORPHAN that shows high affinity binding to several regions of0.691
27Dibucaine0.691
28Encainide0.691
29Physostigmine0.691
30Etorphine0.691
31Fentanyl0.691
32Flecainide0.691
33Fluspirilene0.691
34Guanfacine0.691
35hydrocodone0.691
36Hydroxyzine0.691
37isoetharine0.691
38lidoflazine0.691
39Loratadine0.691
40Loxapine0.691
41Lynestrenol0.691
42Meclizine0.691
43Meperidine0.691
44Nebivolol0.691
45Nefopam Non-narcotic analgesic chemically similar to ORPHENADRINE. Its mechanism of action is unclear. It is used for0.691
46Nortriptyline0.691
47Nylidrin0.691
48Oxycodone0.691
49Perphenazine0.691
50Phentolamine0.691

Showing top 50 of 60 compounds. Use the BiohacksAI search to explore all KAPPA-TYPE modulators.

About KAPPA-TYPE as a Drug Target

KAPPA-TYPE (Kappa-type opioid receptor (human)) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 60 compounds with documented KAPPA-TYPE interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

KAPPA-TYPE inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.